Greenbrook TMS Inc. Stock News

Brokerages predict that Greenbrook TMS Inc. (NASDAQ:GBNH) will report sales of $14.95 million for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Greenbrook TMSs earnings, with estimates ranging from $14.10 million to $15.70 million. Greenbrook TMS reported sales of $9.91 million in the same quarter last year, which indicates []

Greenbrook TMS (NASDAQ:GBNH) had its price target decreased by Desjardins from C$20.00 to C$18.50 in a research report released on Tuesday, The Fly reports. Desjardins currently has a buy rating on the stock. Desjardins also issued estimates for Greenbrook TMSs FY2021 earnings at ($1.53) EPS and FY2022 earnings at ($1.30) EPS. A number of other []

Shares of Greenbrook TMS Inc. (NASDAQ:GBNH) have been assigned a consensus recommendation of Buy from the six research firms that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have covered the stock in the last year is $19.04. []

Greenbrook TMS, Inc. (GBNH) CEO William Leonard on Q3 2021 Results - Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its third quarter 2021 operational and financial results after market hour

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the Uni

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the Uni

Greenbrook TMS Inc (NASDAQ: GBNH) has agreed to acquire Achieve TMS East LLC and Achieve TMS Central LLC. Greenbrook is a provider of Transcranial Magnetic Stimulation (TMS) therapy in the U.S.

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the Uni

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the Uni

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2021 (“Q2 2021”) operational and financial resul

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its second quarter 2021 operational and financial results after market hou

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announced that it has elected to withdraw its previously announced public offering

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the Unit